Literature DB >> 16907909

Defective maturation of dendritic cells in common variable immunodeficiency.

T H Scott-Taylor1, M R Green, M Raeiszadeh, S Workman, A D Webster.   

Abstract

Monocyte-derived dendritic cells (MdDCs) from many patients with common variable immunodeficiency (CVID) have been shown recently to have reduced expression of surface molecules associated with maturity. Using flow cytometry and confocal microscopy, we now show that this is due to a partial failure to fix Class II DR molecules on the surface during procedures that induce full maturation in vitro in cells from normal subjects. Major histocompatibility complex (MHC) class I, CD86 and CD83 expression were expressed normally, but CD40 was reduced. These abnormalities are unlikely to be due to prior in vivo exposure of monocytes to lipopolysaccharide (LPS), as addition of LPS to monocytes from normal subjects in vitro caused a different pattern of changes. CVID MdDCs retained Class II DR in the cytoplasm during maturation, showed increased internalization of cross-linked Class II DR surface molecules and were unable to polarize DR within a lipid raft at contact sites with autologous lymphocytes. These cells retained some features of monocytes, such as the ability to phagocytose large numbers of fixed yeast and fluorescent carboxylated microspheres and expression of surface CD14. These abnormalities, if reflected in vivo, could compromise antigen presentation and may be a fundamental defect in the mechanism of the antibody deficiency in a substantial subset of CVID patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907909      PMCID: PMC1809697          DOI: 10.1111/j.1365-2249.2006.03152.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Natural adjuvants: endogenous activators of dendritic cells.

Authors:  S Gallucci; M Lolkema; P Matzinger
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  MHC class II compartments in human dendritic cells undergo profound structural changes upon activation.

Authors:  Nicolas Barois; Blandine de Saint-Vis; Serge Lebecque; Hans J Geuze; Monique J Kleijmeer
Journal:  Traffic       Date:  2002-12       Impact factor: 6.215

4.  Cutting edge: dendritic cell actin cytoskeletal polarization during immunological synapse formation is highly antigen-dependent.

Authors:  Monther M Al-Alwan; Robert S Liwski; S M Mansour Haeryfar; William H Baldridge; David W Hoskin; Geoffrey Rowden; Kenneth A West
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

Review 5.  Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells.

Authors:  J G Tew; J Wu; D Qin; S Helm; G F Burton; A K Szakal
Journal:  Immunol Rev       Date:  1997-04       Impact factor: 12.988

6.  Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID).

Authors:  A J Stagg; M Funauchi; S C Knight; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

7.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

8.  Clusters of glycolipid and glycosylphosphatidylinositol-anchored proteins in lymphoid cells: accumulation of actin regulated by local tyrosine phosphorylation.

Authors:  T Harder; K Simons
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

9.  Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).

Authors:  C Groth; R Drager; K Warnatz; G Wolff-Vorbeck; S Schmidt; H Eibel; M Schlesier; H-H Peter
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

10.  Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells.

Authors:  M Kleijmeer; G Ramm; D Schuurhuis; J Griffith; M Rescigno; P Ricciardi-Castagnoli; A Y Rudensky; F Ossendorp; C J Melief; W Stoorvogel; H J Geuze
Journal:  J Cell Biol       Date:  2001-10-01       Impact factor: 10.539

View more
  10 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

2.  Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.

Authors:  Sarah Casulli; Hélène Coignard-Biehler; Karima Amazzough; Michka Shoai-Tehrani; Jagadeesh Bayry; Nizar Mahlaoui; Carole Elbim; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 3.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

4.  Multiple malignancies in a female patient with common variable immunodeficiency syndrome.

Authors:  Milena Todorovic; Bela Balint; Bosko Andjelic; Biljana Mihaljevic
Journal:  Singapore Med J       Date:  2014-10       Impact factor: 1.858

5.  Curcumin for the prevention of progression in monoclonal gammopathy of undetermined significance: A word of caution.

Authors:  A J M Vermorken; J Zhu; W J M VAN DE Ven; Y Cui; J P Fryns
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

6.  TLR-mediated B cell defects and IFN-α in common variable immunodeficiency.

Authors:  Joyce E Yu; Li Zhang; Lin Radigan; Silvia Sanchez-Ramon; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2011-11-03       Impact factor: 8.317

7.  Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.

Authors:  E Taraldsrud; B Fevang; P Aukrust; K H Beiske; Y Fløisand; S Frøland; H Rollag; J Olweus
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

8.  Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels.

Authors:  R R Barbosa; S P Silva; S L Silva; R Tendeiro; A C Melo; E Pedro; M P Barbosa; M C P Santos; R M M Victorino; A E Sousa
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

9.  Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients.

Authors:  Miriam Simón-Fuentes; Silvia Sánchez-Ramón; Miguel A Vega; Angel L Corbí; Ángeles Domínguez-Soto; Lidia Fernández-Paredes; Bárbara Alonso; Kissy Guevara-Hoyer
Journal:  J Clin Immunol       Date:  2022-04-29       Impact factor: 8.542

10.  T-cell activation discriminates subclasses of symptomatic primary humoral immunodeficiency diseases in adults.

Authors:  Marie-Quitterie Picat; Rodolphe Thiébaut; François Lifermann; Xavier Delbrel; Daniel Adoue; Linda Wittkop; Anne-Laure Fauchais; Patrick Rispal; Jean-François Moreau; Jean-François Viallard
Journal:  BMC Immunol       Date:  2014-03-12       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.